Published 7 days ago • loading... • Updated 6 days ago
'We Made Them Pay It Back': NC Attorney General Settles $11 Million Lawsuit with EpiPen Distributor
The agreement includes $4.2 million for the state health plan and lower out-of-pocket costs for families, officials said.
On Thursday, North Carolina Attorney General Jeff Jackson announced an $11 million settlement with Mylan to resolve claims the company inflated EpiPen prices through anti-competitive practices.
Mylan allegedly drove EpiPen costs from roughly $100 to around $600 between 2007 and 2016 by blocking generic competition, misclassifying rebates, and forcing customers to purchase two-packs unnecessarily.
State Treasurer Brad Briner confirmed the State Health Plan and North Carolina Medicaid will each receive $4.2 million, money Briner said will "go right back to keeping premiums down."
Under the agreement, Mylan will increase its generic EpiPen co-pay coupon from $25 to $40, a change Attorney General Jackson said will lower immediate out-of-pocket costs for families.
This settlement follows a $21.4 million agreement reached by then-Attorney General Josh Stein in 2017, signaling continued enforcement against prescription drug manufacturers for anti-competitive behavior.